ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3,1,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
4,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
5,1,Thermal burns of eye,Thermal burns,Injuries by physical agents,Inj&P,N
6,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
7,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
7,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
8,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
9,1,Sudden infant death syndrome,Death and sudden death,Fatal outcomes,Genrl,Y
10,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
11,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11,2,Gastric dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
12,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
13,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
13,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
14,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
14,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
14,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
14,4,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
14,5,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
15,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
15,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
16,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
16,2,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
17,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
17,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
18,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
18,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
18,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
19,1,Flashback,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
19,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
20,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
20,2,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
20,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
21,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
21,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
21,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
22,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
22,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
23,1,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
24,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
25,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
26,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
26,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
26,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
27,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
27,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
28,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
28,2,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
28,3,Respiratory fume inhalation disorder,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
29,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
29,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
30,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
30,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
30,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
31,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
32,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
33,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
33,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
34,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
34,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
35,1,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
35,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
36,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
36,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
36,3,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
37,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
37,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
37,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
38,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
39,1,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
39,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
39,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
39,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
39,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
39,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
39,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
39,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
40,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
40,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
40,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
41,1,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
42,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
42,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
43,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
43,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
44,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
44,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
44,3,Headache,Headaches NEC,Headaches,Nerv,N
44,4,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
44,5,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
44,6,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
45,1,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
45,2,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
46,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
47,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
47,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
48,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
48,2,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
49,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
49,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
49,3,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
49,4,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
49,5,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
49,6,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
49,7,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
49,8,Suspected product tampering,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
49,9,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
50,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
50,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
50,3,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
50,4,Paranasal sinus discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
50,5,Product leakage,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
50,6,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
51,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
52,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
53,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
54,1,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
55,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
55,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
55,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
55,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
56,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
57,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
57,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
57,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
58,1,Headache,Headaches NEC,Headaches,Nerv,N
59,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
60,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
61,1,Device material issue,Device physical property and chemical issues,Device issues,Prod,N
61,2,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
62,1,Headache,Headaches NEC,Headaches,Nerv,N
62,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
62,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
63,1,Headache,Headaches NEC,Headaches,Nerv,N
63,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
63,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
64,1,Headache,Headaches NEC,Headaches,Nerv,N
64,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
64,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
65,1,Headache,Headaches NEC,Headaches,Nerv,N
66,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
67,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
68,1,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
68,2,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
68,3,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
